Advanced glycation endproducts in horses with insulin-induced laminitis (Q38405889)

2 September 2017

title

Advanced glycation endproducts in horses with insulin-induced laminitis (English)

1 reference

2 September 2017

1

M. A. de Laat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22240145

22 December 2024

4

C. M. McGowan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22240145

22 December 2024

author name string

M. T. Kyaw-Tanner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22240145

22 December 2024

M. N. Sillence

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22240145

22 December 2024

C. C. Pollitt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22240145

22 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22240145

22 December 2024

publication date

26 December 2011

1 reference

full work available at URL

2 September 2017

https://eprints.qut.edu.au/51408/1/51408_Authors_Final_Version.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22240145

https://api.elsevier.com/content/article/PII:S0165242711004843?httpAccept=text/xml

22 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

https://api.elsevier.com/content/article/PII:S0165242711004843?httpAccept=text/plain

22 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Veterinary Immunology and Immunopathology

22 December 2024

published in

1 reference

2 September 2017

volume

145

1 reference

2 September 2017

issue

1-2

1 reference

2 September 2017

page(s)

395-401

1 reference

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Glucose transport in the equine hoof

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Glycation products and the pathogenesis of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Nonenzymatic glycosylation of macromolecules. Prospects of pharmacologic modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Role of Oxidative Tissue Injury in the Pathophysiology of Experimentally Induced Equine Laminitis: A Comparison of 2 Models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Cloning and expression of ADAM-related metalloproteases in equine laminitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Hyperinsulinemic laminitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

The pathogenesis of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Presence of mononuclear cells in normal and affected laminae from the black walnut extract model of laminitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced glycation end products strongly activate platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Metabolic syndrome-From human organ disease to laminar failure in equids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Oxidative stress and diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Glucose tolerance and insulin sensitivity in ponies and Standardbred horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Diabetes mellitus in a domesticated Spanish mustang

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Laminar xanthine oxidase, superoxide dismutase and catalase activities in the prodromal stage of black-walnut induced equine laminitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced glycation endproducts: from precursors to RAGE: round and round we go.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

7 January 2021

The dark side of glucose

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Analyzing real-time PCR data by the comparative C(T) method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced glycation end products (AGEs) activate mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced glycation end-products: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Inflammatory and redox status of ponies with a history of pasture-associated laminitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Immunohistochemical distribution of laminin-332 and collagen type IV in the basement membrane of normal horses and horses with induced laminitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced glycation end products, oxidative stress and diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Advanced Glycation End Products (AGEs), Oxidative Stress and Diabetic Retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products

7 January 2021

41

1 reference

https://api.crossref.org/works/10.1016/J.VETIMM.2011.12.016

22 December 2024

Identifiers

1 reference

release_3x2hsjtzivbv3pfjn3uw7scjsy

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3x2hsjtzivbv3pfjn3uw7scjsy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference